Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Acceleron Pharma Company Profile (NASDAQ:XLRN)

Consensus Ratings for Acceleron Pharma (NASDAQ:XLRN) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $51.00 (32.81% upside)

Analysts' Ratings History for Acceleron Pharma (NASDAQ:XLRN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/14/2014Leerink SwannInitiated CoverageOutperform$57.00ViewTweet This Rating  Share This Rating on StockTwits
8/13/2014FBR Capital MarketsInitiated CoverageOutperform$47.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2014Piper JaffrayBoost Price TargetOverweight$35.00 -> $65.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014Citigroup Inc.Boost Price Target$50.00ViewTweet This Rating  Share This Rating on StockTwits
12/12/2013JMP SecuritiesReiterated RatingOutperform$32.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
10/14/2013JMP SecuritiesInitiated CoverageOutperform$32.00ViewTweet This Rating  Share This Rating on StockTwits
10/14/2013Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
10/14/2013Citigroup Inc.Initiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
10/14/2013Piper JaffrayInitiated CoverageOverweight$32.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/27/2012 forward)